Story thread · 2 reports / 2 sources
FDA starts review of Roche’s multiple sclerosis pill
biopharmadive.com · 6h · first report
The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.
The coverage
- Roche multiple sclerosis pill gets FDA priority review
seekingalpha.com · 4h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.